Paper
Organic & Biomolecular Chemistry
Parliament and Royal Decree 1201/2005, and were approved by
the ethics committee on animal experimentation of Hospital
General Universitario Gregorio Marañon.
7 (a) O. Rolland, C.-O. Turrin, A.-M. Caminade and
J.-P. Majoral, New J. Chem., 2009, 33, 1809; (b) R. Duncan
and L. Izzo, Adv. Drug Delivery Rev., 2005, 57, 2215–2237.
8 (a) L. Chonco, M. Pion, E. Vacas, B. Rasines, M. Maly,
M. J. Serramía, L. López-Fernández, J. de la Mata,
S. Alvarez, R. Gómez and M. A. Muñoz-Fernández, J. Con-
trolled Release, 2012, 161, 949–958; (b) J. L. Jiménez,
M. Pion, F. J. D. L. Mata, R. Gomez, E. Muñoz, M. Leal and
M. A. Muñoz-Fernandez, New J. Chem., 2012, 36, 299–309;
(c) B. Rasines, J. Sánchez-Nieves, M. Maiolo, M. Maly,
L. Chonco, J. L. Jiménez, M. Á. Muñoz-Fernández, F. J. de
la Mata and R. Gómez, Dalton Trans., 2012, 41, 12733–
12748.
9 (a) E. Vacas-Cordoba, E. Arnaiz, M. Relloso, C. Sanchez-
Torres, F. Garcia, L. Perez-Alvarez, R. Gomez, F. J. de la
Mata, M. Pion and M. A. Munoz-Fernandez, AIDS, 2013, 27,
1219–1229; (b) E. Arnaiz, E. Vacas-Cordoba, M. Gala,
M. Pion, R. Gómez, M. A. Muñoz-Fernandez and
F. J. de la Mata, J. Polym. Sci., Part A. Polym. Chem., 2014,
52, 1099–1112.
10 (a) A. Dondoni, Angew. Chem., Int. Ed., 2008, 47, 8995–8997;
(b) K. L. Killops, L. M. Campos and C. J. Hawker, J. Am.
Chem. Soc., 2008, 130, 5062–5064; (c) C. Rissing and
D. Y. Son, Organometallics, 2008, 27, 5394–5397;
(d) C. Rissing and D. Y. Son, Organometallics, 2009, 28,
3167–3172; (e) R. K. Roy and S. Ramakrishnan, J. Polym.
Sci., Part A: Polym. Chem., 2011, 49, 1735–1744.
11 (a) A. W. van der Made, P. W. N. M. van Leeuwen, J. C. De
Wilde and R. A. C. Brandes, Adv. Mater., 1993, 5, 466–468;
(b) A. W. van der Made and P. W. N. M. van Leeuwen,
J. Chem. Soc., Chem. Commun., 1992, 1400–1401;
(c) J. W. J. Knapen, A. W. van der Made, J. C. de Wilde,
P. N. M. W. Van Leeuwen, P. Wijkens, D. M. Grove and
G. van Koten, Nature, 1994, 372, 659–663; (d) D. Seyferth,
D. Y. Son, A. L. Rheingold and R. L. Ostrander, Organo-
metallics, 1994, 13, 2682–2690; (e) G. R. Newkome and
C. Shreiner, Chem. Rev., 2010, 110, 6338–6442.
Acknowledgements
This work has been supported by grants from CTQ2011-23245
(MINECO) and Consortium NANODENDMED ref S2011/
BMD-2351 (CM) to R. G. and UAH2011/EXP-037 (University of
Alcalá) to F. J. M. This work was supported by grants from
Fondos de Investigación Sanitaria ISCIII (INTRASALUD PI09/
02029, P509102669), Fundación Eugenio Rodríguez Pascual
Red Temática de Investigación Cooperativa Sanitaria ISCIII
(RETIC RD06/0006/0035 and RD12/0017/0037), Red Nacional
de Biobancos (RD09/0076/00103), INDISNET S-2011-BMD2332,
and FIPSE to M. A. M. F. Programa de Investigacion de la Con-
sejeria de Sanidad de la Comunidad de Madrid (PI11/00888)
to JLJF. Marek Maly gratefully acknowledges project GACR
13-06989S. This study was also supported by CIBER-BBN
financed by the Instituto de Salud Carlos III, with assistance
from the European Regional Development Fund.
References
1 WHO/UNAIDS Global Report 2013.
2 N. S. Padian, A. Buvé, J. Balkus, D. Serwadda and W. Cates Jr.,
Lancet, 2008, 372, 585–599.
3 (a) K. K. Ariën, V. Jespers and G. Vanham, Rev. Med. Virol.,
2011, 21, 110–133; (b) L. C. du Toit, V. Pillay and
Y. E. Choonara, Adv. Drug Delivery Rev., 2010, 62, 532–546;
(c) J. Nuttall, Drugs, 2010, 70, 1231–1243.
4 M. Lüscher-Mattli, Antivir. Chem. Chemother., 2000, 11,
249–259.
5 (a) B. Cutler and J. Justman, Lancet Infect. Dis., 2008, 8,
685–697; (b) V. Dzmitruk, D. Shcharbin, E. Pedziwiatr-Wer-
bicka and M. Bryszewska, Adv. Nanocompos. Technol., 2011,
361–374; (c) R. E. Haaland, T. Evans-Strickfaden, A. Holder, 12 J. Sánchez-Nieves, P. Ortega, M. Á. Muñoz-Fernández,
C. P. Pau, J. M. McNicholl, S. Chaikummao,
R. Gómez and F. J. de la Mata, Tetrahedron, 2010, 66, 9203–
W. Chonwattana and C. E. Hart, Antimicrob. Agents Che-
9213.
mother., 2012, 56, 3592–3596; (d) A. S. Ham, L. C. Rohan, 13 B. Korthals, M. C. Morant-Miñana, M. Schmid and
A. Boczar, L. Yang, K. W. Buckheit and R. W. Buckheit, S. Mecking, Macromolecules, 2010, 43, 8071–8078.
Pharm. Res., 2012, 29, 1897–1907; (e) S. Telwatte, K. Moore, 14 P. Eckstein, M. C. N. Jackson, N. Millman and A. J. Sobrero,
A. Johnson, D. Tyssen, J. Sterjovski, M. Aldunate, J. Reprod. Fertil., 1969, 20, 85–93.
P. R. Gorry, P. A. Ramsland, G. R. Lewis, J. R. A. Paull, 15 L. Van Damme, G. Ramjee, M. Alary, B. Vuylsteke,
S. Sonza and G. Tachedjian, Antiviral Res., 2011, 90, 195–
199; (f) K. J. Whaley, J. Hanes, R. Shattock, R. A. Cone and
D. R. Friend, Antiviral Res., 2010, 88, S55–S66.
V. Chandeying, H. Rees, P. Sirivongrangson, L. Mukenge-
Tshibaka, V. Ettiègne-Traoré, C. Uaheowitchai, S. S. Karim,
B. Mâsse, J. Perriëns and M. Laga, COL-1492 Study Group,
Lancet, 2002, 360, 1892–1892.
6 (a) P. Kissinger, C. R. Cohen, J. Brown, A.-B. Moscicki,
E. A. Bukusi, J. R. A. Paull, C. F. Price and S. Shiboski, PLoS 16 A. W. Bosman, H. M. Janssen and E. W. Meijer, Chem. Rev.,
One, 2011, 6, e16258; (b) C. F. Price, D. Tyssen, S. Sonza, 1999, 99, 1665–1688.
A. Davie, S. Evans, G. R. Lewis, S. Xia, T. Spelman, 17 D. A. Case, T. A. Darden, C. T. E. III, C. L. Simmerling,
P. Hodsman, T. R. Moench, A. Humberstone, J. R. A. Paull
and G. Tachedjian, PLoS One, 2011, 6, 1–12; (c) R. Rupp,
S. L. Rosenthal and L. R. Stanberry, Int. J. Nanomedicine,
2007, 2, 561–566.
J. Wang, R. E. Duke, R. Luo, R. C. Walker, W. Zhang,
K. F. Merz, B. Roberts, S. Hayik, A. Roitberg, G. Seabra,
J. Swails, A. W. Goetz, I. Kolossváry, K. F. Wong, F. Paesani,
J. Vanicek, R. M. Wolf, J. Liu, X. Wu, S. R. Brozell,
3236 | Org. Biomol. Chem., 2014, 12, 3222–3237
This journal is © The Royal Society of Chemistry 2014